Sarcopenia: European consensus on definition and diagnosis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 80 of the 80 references it cites were found in a registry or an index.
Abstract
The European Working Group on Sarcopenia in Older People (EWGSOP) developed a practical clinical definition and consensus diagnostic criteria for age-related sarcopenia. EWGSOP included representatives from four participant organisations, i.e. the European Geriatric Medicine Society, the European Society for Clinical Nutrition and Metabolism, the International Association of Gerontology and Geriatrics—European Region and the International Association of Nutrition and Aging. These organisations endorsed the findings in the final document. The group met and addressed the following questions, using the medical literature to build evidence-based answers: (i) What is sarcopenia? (ii) What parameters define sarcopenia? (iii) What variables reflect these parameters, and what measurement tools and cut-off points can be used? (iv) How does sarcopenia relate to cachexia, frailty and sarcopenic obesity? For the diagnosis of sarcopenia, EWGSOP recommends using the presence of both low muscle mass + low muscle function (strength or performance). EWGSOP variously applies these characteristics to further define conceptual stages as ‘presarcopenia’, ‘sarcopenia’ and ‘severe sarcopenia’. EWGSOP reviewed a wide range of tools that can be used to measure the specific variables of muscle mass, muscle strength and physical performance. Our paper summarises currently available data defining sarcopenia cut-off points by age and gender; suggests an algorithm for sarcopenia case finding in older individuals based on measurements of gait speed, grip strength and muscle mass; and presents a list of suggested primary and secondary outcome domains for research. Once an operational definition of sarcopenia is adopted and included in the mainstream of comprehensive geriatric assessment, the next steps are to define the natural course of sarcopenia and to develop and define effective treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European Working Group for the Study of Sarcopenia (EWGSOP)156 identified sarcopenia cut-off points and tools for its measurement. They recognized the lack of diagnostic criteria for sarcopenia but integrated low muscle mass and function (strength or performance) in their terminology, believing that the relationship between these two measures is not linear nor bidirectional73,156,181.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This algorithm was meant for clinical application using gait speed (<0.8 m/s) before muscle mass or strength measurement.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [156]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also, the cut-off points for the Asian populations [9] are lower than for the non-Asian individuals [7] in both genders, with young people of the same ethnic group as reference.”
From Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies (2017) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition to the amount of skeletal muscle, other conditions also affect functional outcomes: muscle quality, total body fat, neurologic function, cardiovascular and pulmonary function, and other comorbid conditions.16,208”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In older people, loss of muscle strength is associated with reduced functional capacity and increased health care costs.16”
From Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group (2013) · cites this paper as [16]
Experimental — accuracy not yet measured
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frailty in Older Adults: Evidence for a Phenotype
Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907 · cited 3×
“Men: Based on quartiles of study group (n = 5,317) [27]”
BackgroundGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792 · cited 1×
“The SPPB evaluates balance, gait, strength and endurance by examining an individual’s ability to stand with the feet together in side-by-side, semi-tandem and tandem positions, time to walk 8 ft and time to rise from a chair and return to the seated position five times [58].”
BackgroundEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 13×
“The re- searchers concluded that BIA was a clinically relevant measure muscle function, which would be particularly useful for patients unable or unwilling to perform grip strength tests.”
BackgroundMethodInfluentialPrado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“In conditions such as malignancy, rheumatoid arthritis and ageing, lean bodymass is lost while fat mass may be preserved or even increased [28].”
BackgroundJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“[67] also used standard deviations to define sarcopenia, measured in terms of skeletal muscle index (SMI), where SMI = (skeletal muscle mass/ body mass) × 100.”
BackgroundMethodGoodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083 · cited 3×
“Intramuscular and visceral fat increase with ageing while subcutaneous fat declines [18, 32, 33].”
BackgroundGuralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898 · cited 2×
“suggested that timed usual gait provides a predictive value for the onset of disability [62].”
BackgroundMeaningful change and responsiveness in common physical performance measures in older adults.
Perera, S., Mody, S. H., Woodman, R. C., & Studenski, S. A. (2006) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2006.00701.x · Cited by 2,513 · cited 1×
“Meaningful changes in the SPPB have been defined [59, 60].”
BackgroundEvans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450 · cited 2×
“Sarcopenia is one of the elements of the proposed definition for cachexia [22].”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 1×
“In 1989, Irwin Rosenberg proposed the term ‘sarcopenia’ (Greek ‘sarx’ or flesh + ‘penia’ or loss) to describe this age-related decrease of muscle mass [1, 2].”
Background
Research works printed but not linked: 1
- Abellan van Kan, 2009, Gait speed as a marker of adverse outcomes, 881
Cited by
Items 1,001–1,100 of 1,247
Dawson, J. K., Dorff, T. B., Todd Schroeder, E., Lane, C. J., Gross, M. E., & Dieli-Conwright, C. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4306-9 · Cited by 112
“In addition, our approach to classifying sarcopenia was based solely on muscle mass, rather than the three-outcome criteria of muscle mass, handgrip strength and gait speed developed by the European Working Group on Sarcopenia in Older People (EWGSOP) [55].”
MethodEffects of exercise on cardiovascular performance in the elderly
Vigorito, C., & Giallauria, F. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00051 · Cited by 111
“H. III., Holloszy, J. O., and Ehsani, A. A. (1993). Differences in cardiovascular adaptations to endurance exercise training between older men and women. J. Appl. Physiol. 75, 849–855. Spina, R. J., Turner, M. J., and Ehsani, A. A. (1998). Beta-adrenergic-mediated improvement in left ventricular function by exercise t…”
BackgroundInfluentialMuscle morphology and performance in master athletes: A systematic review and meta-analyses
Mckendry, J., Breen, L., Shad, B. J., & Greig, C. A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.04.007 · Cited by 111
“Moreover, low levels of muscular strength are strongly associated with an elevated risk of functional impairment (Cruz-Jentoft et al., 2010) and all-cause mortality (Ortega et al., 2012; Ruiz et al., 2008).”
BackgroundDevries, M. C., McGlory, C., Bolster, D. R., Kamil, A., Rahn, M., Harkness, L., Baker, S. K., & Phillips, S. M. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqx028 · Cited by 112
A robust neuromuscular system protects rat and human skeletal muscle from sarcopenia
Pannérec, A., Springer, M., Migliavacca, E., Ireland, A., Piasecki, M., Karaz, S., Jacot, G., Métairon, S., Danenberg, E., Raymond, F., et al. (2016) · Aging · doi:10.18632/aging.100926 · Cited by 110
Watanabe, Y., Madarame, H., Ogasawara, R., Nakazato, K., & Ishii, N. (2014) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12117 · Cited by 110
“Sarcopenia is defined as the ageing-related loss of muscle mass and/or strength (Evans, 1995; Rosenberg, 1997; Cruz-Jentoft et al., 2010).”
BackgroundWeight management in older adults
Gill, L. E., Bartels, S. J., & Batsis, J. A. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0161-z · Cited by 109
Muscular effects of vitamin D in young athletes and non-athletes and in the elderly
Koundourakis, N. E., Avgoustinaki, P. D., Malliaraki, N., & Margioris, A. N. (2016) · Hormones · doi:10.14310/horm.2002.1705 · Cited by 109
Comparing SARC-F with SARC-CalF to Screen Sarcopenia in Community Living Older Adults
Bahat, G., Oren, M. M., Yilmaz, O., Kiliç, C., Aydin, K., & Karan, M. A. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1072-y · Cited by 109
Ismail, C., Zabal, J., Hernandez, H. J., Woletz, P., Manning, H., Teixeira, C., DiPietro, L., Blackman, M. R., & Harris-Love, M. O. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00302 · Cited by 107
Creatine supplementation and aging musculoskeletal health
Candow, D. G., Chilibeck, P. D., & Forbes, S. C. (2014) · Endocrine · doi:10.1007/s12020-013-0070-4 · Cited by 107
Limitations of Fat-Free Mass for the Assessment of Muscle Mass in Obesity
Jensen, B., Braun, W., Geisler, C., Both, M., Klückmann, K., Müller, M. J., & Bosy-Westphal, A. (2019) · Obesity Facts · doi:10.1159/000499607 · Cited by 105
Methods, Diagnostic Criteria, Cutoff Points, and Prevalence of Sarcopenia among Older People
Pagotto, V., & Silveira, E. A. (2014) · The Scientific World Journal · doi:10.1155/2014/231312 · Cited by 100
“TheWorkingGroup on Sarcopenia inOlder People (EWGSOP) defined it as a syndrome characterized by the progressive and generalized loss ofmusclemass, strength, and performance [6].”
BackgroundWagenaar, C. A., Dekker, L. H., & Navis, G. J. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.01.005 · Cited by 105
Amino acid sensing in skeletal muscle
Moro, T., Ebert, S. M., Adams, C. M., & Rasmussen, B. B. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.06.010 · Cited by 104
“The late stage of skeletal muscle aging, sarcopenia, has serious health consequences, including falls, immobility, loss of independent living, and increasedmortality [1].”
BackgroundSzlejf, C., Parra-Rodríguez, L., & Rosas-Carrasco, O. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.02.023 · Cited by 104
A comparison of three methods to assess body composition.
Tewari, N., Awad, S., Macdonald, I. A., & Lobo, D. N. (2018) · Nutrition · doi:10.1016/j.nut.2017.09.005 · Cited by 104
Welch, A. A., Kelaiditi, E., Jennings, A., Steves, C. J., Spector, T. D., & MacGregor, A. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2692 · Cited by 100
Osteosarcopenic obesity in women: impact, prevalence, and management challenges
Jafari Nasabian, P., Inglis, J., Kelly, O., & Ilich, J. (2017) · International Journal of Women's Health · doi:10.2147/ijwh.s106107 · Cited by 90
The association between sarcopenic obesity and depressive symptoms in older Japanese adults
Ishii, S., Chang, C., Tanaka, T., Kuroda, A., Tsuji, T., Akishita, M., & Iijima, K. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162898 · Cited by 95
“Therefore, it is reasonable to hypothesize that sarcopenia, a syndrome characterized by progressive, generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes [16], may be associated with depression.”
BackgroundLv, Y., Mao, C., Gao, X., Ji, J. S., Kraus, V. B., Yin, Z., Yuan, J., Chen, H., Luo, J., Zhou, J., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00201-3 · Cited by 102
MRI in the assessment of adipose tissues and muscle composition: how to use it
Huber, F. A., Del Grande, F., Rizzo, S., Guglielmi, G., & Guggenberger, R. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2020.02.06 · Cited by 102
The prevention of osteoporosis and sarcopenia in older adults
Coll, P. P., Phu, S., Hajjar, S. H., Kirk, B., Duque, G., & Taxel, P. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17043 · Cited by 101
Impact of edema on length of calf circumference in older adults
Ishida, Y., Maeda, K., Nonogaki, T., Shimizu, A., Yamanaka, Y., Matsuyama, R., Kato, R., & Mori, N. (2019) · Geriatrics & Gerontology International · doi:10.1111/ggi.13756 · Cited by 97
Wu, C., Chen, K., Hou, M., Chang, Y., Chang, C., Liu, P., Wu, S., Chiu, C., Jou, I., & Chen, C. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12233 · Cited by 98
Dietary protein intake in sarcopenic obese older women
Muscariello, E., Nasti, G., Siervo, M., Di Maro, M., Lapi, D., D'Addio, G., & Colantuoni, A. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s96017 · Cited by 96
Sarcopenic obesity: An appraisal of the current status of knowledge and management in elderly people
Molino, S., Dossena, M., Buonocore, D., & Verri, M. (2016) · The Journal of nutrition, health and aging · doi:10.1007/s12603-015-0631-8 · Cited by 91
Semba, R. D., Gonzalez-Freire, M., Tanaka, T., Biancotto, A., Zhang, P., Shardell, M., Moaddel, R., CHI Consortium, & Ferrucci, L. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz071 · Cited by 94
Henriksen, C., Paur, I., Pedersen, A., Kværner, A. S., Ræder, H., Henriksen, H. B., Bøhn, S. K., Wiedswang, G., & Blomhoff, R. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.12.024 · Cited by 95
“Cut-off values for low muscle mass were set to FFMI (FFM (kg)/height (m2)) 15 kg/m2 for women and 17 kg/m2 for men for moderate malnutrition, according to cut-off values for FFMI proposed for sarcopenia by ESPEN [27,28].”
MethodNutrition and protein energy homeostasis in elderly
Boirie, Y., Morio, B., Caumon, E., & Cano, N. J. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2014.01.008 · Cited by 94
Self-citationEffects of Nrf2 deficiency on mitochondrial oxidative stress in aged skeletal muscle
Kitaoka, Y., Tamura, Y., Takahashi, K., Takeda, K., Takemasa, T., & Hatta, H. (2019) · Physiological Reports · doi:10.14814/phy2.13998 · Cited by 94
Shafiee, G., Ostovar, A., Heshmat, R., Darabi, H., Sharifi, F., Raeisi, A., Mehrdad, N., Shadman, Z., Razi, F., Amini, M. R., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013606 · Cited by 94
Reinders, I., Murphy, R. A., Koster, A., Brouwer, I. A., Visser, M., Garcia, M. E., Launer, L. J., Siggeirsdottir, K., Eiriksdottir, G., Jonsson, P. V., et al. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv016 · Cited by 93
Bauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00561-w · Cited by 83
Self-citationArnold, P., & Bautmans, I. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.07.012 · Cited by 92
“…as the age-related loss of skeletal muscle mass and resulting in an important change in body-composition and function in elderly persons (Rosenberg, 1997), has been extensively described in the literature (Bautmans et al., 2009; Cruz-Jentoft et al., 2010; Fielding et al., 2011; Rosenberg, 2011).”
BackgroundChun, S.-W., Kim, W., & Choi, K. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222040 · Cited by 92
Akune, T., Muraki, S., Oka, H., Tanaka, S., Kawaguchi, H., Tokimura, F., Yoshida, H., Suzuki, T., Nakamura, K., & Yoshimura, N. (2014) · Geriatrics & Gerontology International · doi:10.1111/ggi.12155 · Cited by 91
Growing older with health and vitality: a nexus of physical activity, exercise and nutrition
Witard, O. C., McGlory, C., Hamilton, D. L., & Phillips, S. M. (2016) · Biogerontology · doi:10.1007/s10522-016-9637-9 · Cited by 91
ATP Citrate Lyase Improves Mitochondrial Function in Skeletal Muscle
Das, S., Morvan, F., Jourde, B., Meier, V., Kahle, P., Brebbia, P., Toussaint, G., Glass, D. J., & Fornaro, M. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.006 · Cited by 91
Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
“Aging usually involves a reduction in muscle mass and trophism,(76) a condition that in its most severe manifestations is called sarcopenia.(77) In elderly people, muscle hypotrophy often represents the main cause of important functional limitations, ranging from reduced muscular strength to increased risk of falls.”
BackgroundSarcopenic obesity and cognitive performance
Tolea, M., Chrisphonte, S., & Galvin, J. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s164113 · Cited by 90
Gadelha, A. B., Paiva, F. M. L., Gauche, R., de Oliveira, R. J., & Lima, R. M. (2016) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2016.03.017 · Cited by 91
Mills, S., Lane, J. A., Smith, G. J., Grimaldi, K. A., Ross, R. P., & Stanton, C. (2019) · Nutrients · doi:10.3390/nu11071468 · Cited by 88
“Sarcopenia is described as depletion of muscle mass and reduction of muscle performance which both result from anabolic resistance or boosted protein catabolism [101].”
BackgroundThe effects of resistance training volume on osteosarcopenic obesity in older women
Cunha, P. M., Ribeiro, A. S., Tomeleri, C. M., Schoenfeld, B. J., Silva, A. M., Souza, M. F., Nascimento, M. A., Sardinha, L. B., & Cyrino, E. S. (2018) · Journal of Sports Sciences · doi:10.1080/02640414.2017.1403413 · Cited by 88
Peng, T.-C., Wu, L.-W., Chen, W.-L., Liaw, F.-Y., Chang, Y.-W., & Kao, T.-W. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.11.021 · Cited by 84
Mitchell, C., McGregor, R., D’Souza, R., Thorstensen, E., Markworth, J., Fanning, A., Poppitt, S., & Cameron-Smith, D. (2015) · Nutrients · doi:10.3390/nu7105420 · Cited by 87
Yi, D., Khang, A. R., Lee, H. W., Son, S. M., & Kang, Y. H. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s166875 · Cited by 86
Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria
Xie, W.-Q., Xiao, G.-L., Fan, Y.-B., He, M., Lv, S., & Li, Y.-S. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-019-01435-9 · Cited by 86
Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06831-7 · Cited by 86
Theodorakopoulos, C., Jones, J., Bannerman, E., & Greig, C. A. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.05.002 · Cited by 86
Hita-Contreras, F., Bueno-Notivol, J., Martínez-Amat, A., Cruz-Díaz, D., Hernandez, A. V., & Pérez-López, F. R. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.07.007 · Cited by 86
Sarcopenic obesity: satellite cells in the aging muscle
Thornell, L.-E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283412260 · Cited by 86
Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus
Ida, S., Kaneko, R., Imataka, K., Okubo, K., Shirakura, Y., Azuma, K., Fujiwara, R., & Murata, K. (2021) · Current Diabetes Reviews · doi:10.2174/1573399816666200705210006 · Cited by 85
Wang, Y., Zhao, Z.-J., Kang, X.-R., Bian, T., Shen, Z.-M., Jiang, Y., Sun, B., Hu, H.-B., & Chen, Y.-S. (2020) · Aging · doi:10.18632/aging.104095 · Cited by 85
IL-15 Promotes Human Myogenesis and Mitigates the Detrimental Effects of TNFα on Myotube Development
O’Leary, M. F., Wallace, G. R., Bennett, A. J., Tsintzas, K., & Jones, S. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-13479-w · Cited by 85
The time course of disuse muscle atrophy of the lower limb in health and disease
Hardy, E. J. O., Inns, T. B., Hatt, J., Doleman, B., Bass, J. J., Atherton, P. J., Lund, J. N., & Phillips, B. E. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13067 · Cited by 83
“It is also associated with the prevalence of long-term health conditions, such as type 2 diabetes,(6) and a worse age-matched risk of mortality.(7) It is clear that some muscle loss inevitably occurs as part of the innate ageing process, with an average annual loss of 1% of muscle mass and 3% of strength after the age…”
BackgroundMitochondria and cellular senescence: Implications for musculoskeletal ageing
Habiballa, L., Salmonowicz, H., & Passos, J. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.417 · Cited by 82
Prevention and treatment of sarcopenic obesity in women
Petroni, M. L., Caletti, M. T., Dalle Grave, R., Bazzocchi, A., Aparisi Gómez, M. P., & Marchesini, G. (2019) · Nutrients · doi:10.3390/nu11061302 · Cited by 82
“Abbreviations 6MWT 6-min walking test AE Aerobic exercise ASMM Appendicular skeletal muscle mass BIA Bioelectrical impedance analysis CT Computerized tomography DEXA Dual-energy x-ray absorptiometry EAA Essential amino acids EWGSOP1 European Working Group on Sarcopenia in Older People 1 (2010 criteria) EWGSOP2 Europea…”
MethodInfluentialVan Roie, E., Verschueren, S. M., Boonen, S., Bogaerts, A., Kennis, E., Coudyzer, W., & Delecluse, C. (2011) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2011.05.022 · Cited by 81
Myostatin – The Holy Grail for Muscle, Bone, and Fat?
Buehring, B., & Binkley, N. (2013) · Current Osteoporosis Reports · doi:10.1007/s11914-013-0160-5 · Cited by 79
Bariatric Surgery Outcomes in Sarcopenic Obesity
Mastino, D., Robert, M., Betry, C., Laville, M., Gouillat, C., & Disse, E. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2102-7 · Cited by 79
Sammarco, R., Marra, M., Di Guglielmo, M. L., Naccarato, M., Contaldo, F., Poggiogalle, E., Donini, L. M., & Pasanisi, F. (2017) · Obesity Facts · doi:10.1159/000468153 · Cited by 75
Alcazar, J., Rodriguez-Lopez, C., Ara, I., Alfaro-Acha, A., Rodríguez-Gómez, I., Navarro-Cruz, R., Losa-Reyna, J., García-García, F. J., & Alegre, L. M. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.03.015 · Cited by 77
“The skeletal muscle index (SMI; kg·m−2) was used as a marker of sarcopenia (Cruz-Jentoft et al., 2010; Fielding et al., 2011).”
MethodComparison of Three Screening Methods for Sarcopenia in Community-Dwelling Older Persons
Mo, Y.-H., Zhong, J., Dong, X., Su, Y.-D., Deng, W.-Y., Yao, X.-M., Liu, B.-B., Wang, X.-Q., & Wang, X.-H. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.05.041 · Cited by 73
Isanejad, M., Sirola, J., Mursu, J., Rikkonen, T., Kröger, H., Tuppurainen, M., & Erkkilä, A. T. (2018) · European Journal of Nutrition · doi:10.1007/s00394-017-1422-2 · Cited by 75
Pedrero-Chamizo, R., Gómez-Cabello, A., Mélendez, A., Vila-Maldonado, S., Espino, L., Gusi, N., Villa, G., Casajús, J. A., González-Gross, M., & Ara, I. (2015) · The Journal of nutrition, health and aging · doi:10.1007/s12603-014-0530-4 · Cited by 76
Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean
Chung, J. H., Hwang, H. J., Shin, H.-Y., & Han, C. H. (2016) · Annals of Nutrition and Metabolism · doi:10.1159/000442004 · Cited by 78
Kemmler, W., Teschler, M., Weißenfels, A., Sieber, C., Freiberger, E., & von Stengel, S. (2017) · Osteoporosis International · doi:10.1007/s00198-017-3964-9 · Cited by 71
Pagotto, V., & Silveira, E. A. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.05.009 · Cited by 75
“Despite these limitations, accurate methods such as DXA and alternative measurements (BIA and CC) were utilized to estimate muscle mass, and GS was evaluated as functional measurement (Cruz-Jentoft et al., 2010; Fielding et al., 2011), enabling a more precise and comprehensive evaluation of sarcopenia.”
BackgroundMethodInfluentialDifferential features of muscle fiber atrophy in osteoporosis and osteoarthritis
Terracciano, C., Celi, M., Lecce, D., Baldi, J., Rastelli, E., Lena, E., Massa, R., & Tarantino, U. (2013) · Osteoporosis International · doi:10.1007/s00198-012-1990-1 · Cited by 75
Sarcopenia and sarcopenic obesity classifications and cardiometabolic risks in older women
dos Santos, E. P., Gadelha, A. B., Safons, M. P., Nóbrega, O. T., Oliveira, R. J., & Lima, R. M. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2014.03.012 · Cited by 69
Contribution of muscle satellite cells to sarcopenia
Huo, F., Liu, Q., & Liu, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.892749 · Cited by 74
“In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) defined low muscle function (characterized by low muscle strength) and reduced muscle mass as two criteria for the clinical diagnosis of sarcopenia (Cruz-Jentoft et al., 2010).”
BackgroundChang, S.-F., Lin, P.-C., Yang, R.-S., & Yang, R.-J. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0712-8 · Cited by 74
Batsis, J. A., Zbehlik, A. J., Pidgeon, D., & Bartels, S. J. (2015) · BMC Geriatrics · doi:10.1186/s12877-015-0118-9 · Cited by 74
Imboden, M. T., Swartz, A. M., Finch, H. W., Harber, M. P., & Kaminsky, L. A. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176161 · Cited by 75
Kong, M., Geng, N., Zhou, Y., Lin, N., Song, W., Xu, M., Li, S., Piao, Y., Han, Z., Guo, R., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.12.003 · Cited by 73
Kim, J., Lee, Y., Kye, S., Chung, Y., & Lee, O. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12154 · Cited by 71
A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved
Moreira-Pais, A., Ferreira, R., Oliveira, P. A., & Duarte, J. A. (2022) · GeroScience · doi:10.1007/s11357-021-00510-2 · Cited by 74
Sex differences in the response to resistance exercise training in older people
Da Boit, M., Sibson, R., Meakin, J. R., Aspden, R. M., Thies, F., Mangoni, A. A., & Gray, S. R. (2016) · Physiological Reports · doi:10.14814/phy2.12834 · Cited by 73
“The loss of skeletal muscle mass and function can occur in many conditions, such as sarcopenia (age related atrophy), cachexia (wasting associated with disease), and general disuse (Baumgartner et al. 1998; Cruz-Jentoft et al. 2010).”
Bering, T., Diniz, K. G. D., Coelho, M. P. P., Vieira, D. A., Soares, M. M. S., Kakehasi, A. M., Correia, M. I. T. D., Teixeira, R., Queiroz, D. M. M., Rocha, G. A., et al. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12269 · Cited by 73
Physical Activity and Oxidative Stress in Aging
Militello, R., Luti, S., Gamberi, T., Pellegrino, A., Modesti, A., & Modesti, P. A. (2024) · doi:10.20944/preprints202404.0293.v1 · Cited by 73
Ashtary-Larky, D., Bagheri, R., Abbasnezhad, A., Tinsley, G. M., Alipour, M., & Wong, A. (2020) · British Journal of Nutrition · doi:10.1017/s000711452000224x · Cited by 72
Cheng, H., Kong, J., Underwood, C., Petocz, P., Hirani, V., Dawson, B., & O’Leary, F. (2018) · British Journal of Nutrition · doi:10.1017/s0007114517003816 · Cited by 72
Vignaud, J., Loiseau, C., Hérault, J., Mayer, C., Côme, M., Martin, I., & Ulmann, L. (2023) · Antioxidants · doi:10.3390/antiox12051050 · Cited by 72
Gardner, M. P., Lightman, S., Sayer, A. A., Cooper, C., Cooper, R., Deeg, D., Ebrahim, S., Gallacher, J., Kivimaki, M., Kumari, M., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.04.016 · Cited by 72
Lewis, L. N., Hayhoe, R. P., Mulligan, A. A., Luben, R. N., Khaw, K.-T., & Welch, A. A. (2020) · The Journal of Nutrition · doi:10.1093/jn/nxaa221 · Cited by 72
Munk, T., Tolstrup, U., Beck, A. M., Holst, M., Rasmussen, H. H., Hovhannisyan, K., & Thomsen, T. (2016) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12307 · Cited by 71
Jendricke, P., Centner, C., Zdzieblik, D., Gollhofer, A., & König, D. (2019) · Nutrients · doi:10.3390/nu11040892 · Cited by 70
“An increase in age is well-reported to be associated with a decrease in muscle mass and function [5], which again has a major impact on risk of falls [6] and activity of daily living and thus quality of life [7].”
BackgroundAssociation between low testosterone levels and sarcopenia in cirrhosis: A cross-sectional study
Moctezuma-Velázquez, C., Low, G., Mourtzakis, M., Ma, M., Burak, K. W., Tandon, P., & Montano-Loza, A. J. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.0930 · Cited by 70
Pipek, L. Z., Baptista, C. G., Nascimento, R. F. V., Taba, J. V., Suzuki, M. O., do Nascimento, F. S., Martines, D. R., Nii, F., Iuamoto, L. R., Carneiro-D’Albuquerque, L. A., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237740 · Cited by 71
Barrea, L., Macchia, P. E., Di Somma, C., Napolitano, M., Balato, A., Falco, A., Savanelli, M. C., Balato, N., Colao, A., & Savastano, S. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0889-6 · Cited by 70
Kim, J. H., Choi, S. H., Lim, S., Kim, K. W., Lim, J. Y., Cho, N. H., Park, K. S., & Jang, H. C. (2014) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2013.11.002 · Cited by 67
“Second, ‘‘whole body’’ skeletal muscle mass was measured in previous studies instead of ASM, which is known to be associated with muscle strength, physical function and activity of daily living in elderly people (Baumgartner, 2000; Cruz-Jentoft et al., 2010).”
BackgroundMethodMurray, T. É., Williams, D., & Lee, M. J. (2017) · Abdominal Radiology · doi:10.1007/s00261-017-1124-5 · Cited by 69
Sbrignadello, S., Göbl, C., & Tura, A. (2022) · Nutrients · doi:10.3390/nu14091864 · Cited by 68
““Tweet” on StudyCharacteristics/Outcomes BIA Estimated/Calculated Parameters No. of Subjects Publication Year No. of Citations [41] In T2DM, sarcopenia appears significantly associated with impaired microcirculation, defined as low skin perfusion pressure Appendicular skeletal muscle mass (as a sum of lean mass in the…”
BackgroundMethodInfluentialIdentification of sarcopenic obesity in postmenopausal women: a cutoff proposal
Oliveira, R. J., Bottaro, M., Júnior, J. T., Farinatti, P. T. V., Bezerra, L. A., & Lima, R. M. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500135 · Cited by 68
Resistance exercise impacts lean muscle mass in women with polycystic ovary syndrome
KOGURE, G. S., MIRANDA-FURTADO, C. L., SILVA, R. C., MELO, A. S., FERRIANI, R. A., DE SÁ, M. F. S., & REIS, R. M. D. (2016) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000822 · Cited by 68
Poggiogalle, E., Migliaccio, S., Lenzi, A., & Donini, L. M. (2014) · Endocrine · doi:10.1007/s12020-014-0315-x · Cited by 67
A High Serum Cortisol/DHEA-S Ratio Is a Risk Factor for Sarcopenia in Elderly Diabetic Patients
Yanagita, I., Fujihara, Y., Kitajima, Y., Tajima, M., Honda, M., Kawajiri, T., Eda, T., Yonemura, K., Yamaguchi, N., Asakawa, H., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2018-00271 · Cited by 67
Frailty trajectories in adult lung transplantation: a cohort study
Venado, A., McCulloch, C., Greenland, J. R., Katz, P., Soong, A., Shrestha, P., Hays, S., Golden, J., Shah, R., Leard, L. E., et al. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.03.006 · Cited by 67
Markov, A., Hauser, L., & Chaabene, H. (2023) · Sports Medicine · doi:10.1007/s40279-022-01764-2 · Cited by 66
“These alterations are known to be more prevalent in older populations [24], but evidence indicates that the decrease in muscle mass and function (i.”
Background
Metadata
- Authors
- Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., Topinková, E., Vandewoude, M., & Zamboni, M.
- Affiliations
- Hospital Universitario Ramón y Cajal (ES)
- Damiaan Dicht bij het leven (BE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Clermont Université 4 , UFR Médecine, UMR 1019, F-63001 Clermont-Ferrand , France
- Uppsala University (SE)
- Università Cattolica del Sacro Cuore (IT)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital of Geneva (CH)
- Hôpital de La Grave (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Charles University (CZ)
- University of Antwerp (BE)
- University of Verona (IT)
- Corresponding author
- Cruz-Jentoft, Alfonso J.
- ORCID
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-04-13
- Volume
- 39
- Issue
- 4
- Pages
- 412-423
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- PMC
- PMC2886201
- OpenAlex
- W2102902846
- Cited by
- 11,601
- References
- 80
- Citations by year
- 2026: 468 · 2025: 791 · 2024: 879 · 2023: 913 · 2022: 1031 · 2021: 1056 · 2020: 1131 · 2019: 1021 · 2018: 1059 · 2017: 811 · 2016: 685 · 2015: 591 · 2014: 494 · 2013: 290 · 2012: 207
- FWCI
- 142.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Age and Ageing (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- reroDoc Digital Library (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- European Geriatric Medicine Society
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenia, older adults, diagnostic criteria, muscle mass, muscle strength, physical performance, walking speed, grip strength, sarcopenic obesity, frailty, cachexia, pre-sarcopenia, cut-off values, case-finding algorithms, comprehensive geriatric assessment
- MeSH terms
- Aged, Aged, 80 and over, Aging, Cachexia, Female, Humans, Male, Obesity, Geriatric Assessment, Frail Elderly, Muscle, Skeletal, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

